NDAORALCAPSULE
Approved
Dec 2025
Lifecycle
Launch
Competitive Pressure
0/100
Clinical Trials
15
Clinical Trials (5)
A Study to Evaluate Tradipitant on Treating Nausea and Vomiting Induced by GLP-1R Agonist Use
Started Feb 2026
280 enrolled
Nausea and VomitingObesity
A Study to Measure the Effects of Using Tradipitant on Nausea and Vomiting After GLP-1R Agonist Use
Started Feb 2025
124 enrolled
Obesity
Open Label Safety Study of Tradipitant in Idiopathic and Diabetic Gastroparesis
Started Jan 2024
100 enrolled
Idiopathic GastroparesisDiabetic GastroparesisGastroparesis
Motion Serifos: A Study to Investigate the Efficacy of Tradipitant in Participants Affected by Motion Sickness
Started Sep 2023
316 enrolled
Motion Sickness
Motion Delos: An Open Label Safety and Efficacy of Tradipitant in Participants Affected by Motion Sickness
Started Feb 2023
705 enrolled
Motion Sickness
Loss of Exclusivity
LOE Date
Aug 9, 2036
127 months away
Patent Expiry
Aug 9, 2036
Exclusivity Expiry
Dec 30, 2030
External Resources